AbbVie ABBV
NYSE ABBV
$291.23 +3.02 (+1.05%)
At close: Nov 6, 2026 · 4:00 PM EST

AbbVie (ABBV) Short-Term Debt repayments (2024 - 2026)

Updated

AbbVie's Short-Term Debt repayments came in at $2 billion for Q1 2026, up 152.8% from the prior quarter.

Analysis

AbbVie (ABBV) Short-Term Debt repayments (2024 - 2026) Analysis & Trends

For FY2025, AbbVie's Short-Term Debt repayments was $2.8 billion, down 44.1% from FY2024.

  • Going back by year, Short-Term Debt repayments was $5.01 billion in FY2024.
  • The five-year range for quarterly Short-Term Debt repayments is $3 million (Q2 2024) to $5.01 billion (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 6.63 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Bn
Dec 31, 2025 791.00 Mn
Sep 30, 2025 2.01 Bn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 5.01 Bn
API Access

AbbVie Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=ABBV&period=max&api_key=YOUR_API_KEY